ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: NCFA Offers Grants For Research On Impact Of DRGs; ACCC Leaders Dispute HCFA Chief

March 8, 1985

Fox Chase Biochemist Automates DNA Production

July 20, 1990

Recombinant Protein C Cuts Risk Of Sepsis Death

February 22, 2002

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

New Approaches To Therapy For Difficult Cancers Presented

June 29, 2007

NCI funds nine centers for $14.9 million integrative biology program.

October 29, 2004